| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $6.32B | +9.2% |
| Cost of Revenue | $3.70B | +10.8% |
| R&D Expense | $451.4M | +13.7% |
| SG&A Expense | $1.00B | +6.9% |
| Operating Income | -$188.4M | -58.4% |
| Pre-tax Income | -$53.2M | -310.0% |
| Income Tax | -$2.90B | — |
| Net Income | $2.84B | — |
| EPS (Basic) | $6.92 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.13B | +49.1% |
| Short-term Investments | $705.2M | -42.4% |
| Current Assets | $2.92B | -1.1% |
| Total Assets | $9.03B | +66.1% |
| Current Liabilities | $4.53B | +16.6% |
| Long-term Debt | $1.05B | +5.8% |
| Total Liabilities | $5.76B | +23.3% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.17B | +37.5% |
| Investing Cash Flow | $406.7M | +178.5% |
| Financing Cash Flow | -$685.5M | -339.8% |
| — |
| EPS (Diluted) | $6.81 | — |
| Stockholders' Equity |
| $3.27B |
| +326.8% |